Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is N/A as of Tuesday, October 6, 2026.
NET PROFIT MARGIN
N/A
Market Cap
$134.99M
Net Profit Margin
27.54%
TTM Avg
-18.99%
3Y Avg
-63.93%
5Y Avg
-73.34%
Market Cap
$136.66M
Net Profit Margin
-396.52%
TTM Avg
-411.88%
3Y Avg
-411.88%
5Y Avg
-411.88%
Market Cap
$134.21M
Net Profit Margin
-10.40%
TTM Avg
-6.28%
3Y Avg
-16.07%
5Y Avg
-47.85%
Market Cap
$132.66M
Net Profit Margin
-7.79%
TTM Avg
-6.13%
3Y Avg
-5.81%
5Y Avg
-0.54%
Market Cap
$137.11M
Net Profit Margin
-4.03%
TTM Avg
-12.22%
3Y Avg
-25.92%
5Y Avg
-21.35%
Market Cap
$132.64M
Net Profit Margin
-90.61%
TTM Avg
-39.94%
3Y Avg
-42.38%
5Y Avg
-48.96%
Market Cap
$138.93M
Net Profit Margin
-153.61%
TTM Avg
-101.12%
3Y Avg
-50.56%
5Y Avg
-33.71%
Market Cap
$140.31M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-3984.32%
5Y Avg
-3047.80%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Freenome, Inc. (FRNM) | $135.33M | N/A | N/A | N/A | N/A |
| Organigram Global Inc. (OGI)vs › | $134.99M | 27.54% | -18.99% | -63.93% | -73.34% |
| Atrium Therapeutics, Inc. (RNA)vs › | $136.66M | -396.52% | -411.88% | -411.88% | -411.88% |
| LifeMD, Inc. (LFMD)vs › | $134.21M | -10.40% | -6.28% | -16.07% | -47.85% |
| AirSculpt Technologies, Inc. (AIRS)vs › | $132.66M | -7.79% | -6.13% | -5.81% | -0.54% |
| KORU Medical Systems, Inc. (KRMD)vs › | $137.11M | -4.03% | -12.22% | -25.92% | -21.35% |
| Health Catalyst, Inc. (HCAT)vs › | $132.64M | -90.61% | -39.94% | -42.38% | -48.96% |
| Alpha Cognition Inc (ACOG)vs › | $138.93M | -153.61% | -101.12% | -50.56% | -33.71% |
| Immuneering Corporation (IMRX)vs › | $140.31M | 0.00% | 0.00% | -3984.32% | -3047.80% |
| Fortress Biotech, Inc. (FBIOP)vs › | $140.52M | 163.32% | -34.49% | -63.76% | -75.19% |
Operating Margin
N/A
Net Profit Margin
N/A
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
